What is the catalog number for CTDP1 Antibody - C-terminal region (ARP65744_P050)?

The catalog number for CTDP1 Antibody - C-terminal region (ARP65744_P050) is ARP65744_P050.

What sizes are available for CTDP1 Antibody - C-terminal region (ARP65744_P050)?

CTDP1 Antibody - C-terminal region (ARP65744_P050) is available in the following size(s): 100 µL.

Is CTDP1 Antibody - C-terminal region (ARP65744_P050) in stock?

CTDP1 Antibody - C-terminal region (ARP65744_P050) is currently made to order / not held in immediate stock. Contact us for lead time.

What buffer is this product supplied in?

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Can I request a Safety Data Sheet (SDS) for this product?

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

CTDP1 Antibody - C-terminal region (ARP65744_P050)

Product Specifications

CAS Number

9007-83-4

Gene Name

CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1

Gene Aliases

FCP1, CCFDN

Gene ID

9150

Swiss Prot

Q9Y5B0

Accession Number

NP_430255

Reactivity

Human, Mouse, Rat, Dog, Guinea Pig, Horse, Pig, Rabbit, Zebrafish

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of Human CTDP1

Target

This gene encodes a protein which interacts with the carboxy-terminus of the RAP74 subunit of transcription initiation factor TFIIF, and functions as a phosphatase that processively dephosphorylates the C-terminus of POLR2A (a subunit of RNA polymerase II), making it available for initiation of gene expression. Mutations in this gene are associated with congenital cataracts, facial dysmorphism and neuropathy syndrome (CCFDN) . Alternatively spliced transcript variants encoding different isoforms have been described for this gene.

Partner Proteins

UBC; CDK9; UPP1; PPP2CA; PPP1CA; POLR2A; POLR2C; GRK5; ELP2; ELP3; SUMO2; PRKDC; CDK8; CDK7; INTS8; MED15; MED4; INTS6; INTS1; INTS7; MED16; MED6; MED24; MED7; MED26; MED17; MED23; MED14; MED1; MED8; MED25; INTS3; POLR2J; ERH; POLR2B; STK38; PRMT5; HIST1H

Clonality

Polyclonal

Type

Polyclonal Antibody

Sequence

AHAPDKEPELGGQEEGERDGLCGLGNGCADRKEAETESQNSELSGVTAGE

Applications

Purification

Affinity Purified

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol